Nantahala Capital Management LLC Purchases New Position in OrthoPediatrics Corp. $KIDS

Nantahala Capital Management LLC purchased a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 242,342 shares of the company’s stock, valued at approximately $4,636,002.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in KIDS. AIGH Capital Management LLC acquired a new position in OrthoPediatrics during the 2nd quarter worth about $5,161,000. Wasatch Advisors LP increased its position in OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock valued at $9,865,000 after acquiring an additional 186,357 shares in the last quarter. Roubaix Capital LLC increased its position in OrthoPediatrics by 23.8% in the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock valued at $4,603,000 after acquiring an additional 55,724 shares in the last quarter. Granahan Investment Management LLC raised its stake in shares of OrthoPediatrics by 35.1% in the first quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after acquiring an additional 232,760 shares during the last quarter. Finally, AWM Investment Company Inc. bought a new position in shares of OrthoPediatrics in the second quarter worth about $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Stock Up 1.4%

Shares of OrthoPediatrics stock opened at $23.65 on Friday. The company has a market capitalization of $617.50 million, a P/E ratio of -14.08 and a beta of 0.98. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. The business has a 50-day moving average of $21.41 and a two-hundred day moving average of $18.66. OrthoPediatrics Corp. has a 1 year low of $14.42 and a 1 year high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The business had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. As a group, equities analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on KIDS shares. BTIG Research lifted their target price on OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Truist Financial set a $22.00 price target on OrthoPediatrics in a report on Wednesday, August 5th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Finally, TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $26.44.

Insider Transactions at OrthoPediatrics

In other OrthoPediatrics news, Director David R. Pelizzon sold 18,000 shares of the company’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00. Following the sale, the director directly owned 6,863,464 shares of the company’s stock, valued at approximately $166,644,905.92. This represents a 0.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Jennifer N. Pritzker sold 18,000 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00. Following the completion of the sale, the insider owned 6,863,464 shares of the company’s stock, valued at approximately $166,644,905.92. This represents a 0.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 114,900 shares of company stock worth $2,829,906 in the last three months. Insiders own 32.50% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.